M. Thomas

Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors.

E. Jaffee, D. Pardoll, M. Ewend, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials.

R. Hruban, E. Jaffee, M. Schutte, 1998, The cancer journal from Scientific American.

Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine.

E. Jaffee, T. Greten, D. Pardoll, 1998, Human gene therapy.

Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system.

D. Brat, E. Jaffee, D. Pardoll, 2000, Journal of immunotherapy.

Enhanced immune priming with spatial distribution of paracrine cytokine vaccines.

E. Jaffee, D. Pardoll, H. Levitsky, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Mechanistic target of rapamycin (mTOR) regulates self-sustained quiescence, tumor indolence and late clinical metastasis in a Beclin-1-dependent manner

C. Nicco, F. Batteux, F. Dautry, 2022, bioRxiv.

Imprint of Initial Education and Loss of Ly49C/I in Activated Natural Killer Cells of TAP1-KO and C57BL/6 Wildtype Mice

J. Zimmer, M. Thérésine, H. Slevogt, 2022, Frontiers in Immunology.

A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice

C. Nicco, F. Batteux, M. Jeljeli, 2022, Frontiers in Immunology.

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

E. Jaffee, D. Hunt, V. Engelhard, 1996, Proceedings of the National Academy of Sciences of the United States of America.

LPSlow-Macrophages Alleviate the Outcome of Graft-Versus-Host Disease Without Aggravating Lymphoma Growth in Mice

C. Nicco, F. Batteux, S. Chouzenoux, 2021, Frontiers in Immunology.

Optimal combination of arsenic trioxide and copper ions to prevent autoimmunity in a murine HOCl-induced model of systemic sclerosis

C. Nicco, F. Batteux, M. Thomas, 2023, Frontiers in Immunology.

PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients

C. Nicco, F. Batteux, S. Chouzenoux, 2023, Inflammopharmacology.